ArticleJournal of Alzheimer's disease reports
Identifying facility-level and infrastructure-level bottlenecks in Japan's lecanemab rollout through an online survey of dementia specialists.
Saki Nakashima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.